Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
-0.0010 (-7.69%)
Aug 5, 2026, 1:13 PM AEST

Cynata Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-8.4-9.39-9.74-14.28-5.45-7.69
Depreciation & Amortization
----0.280.28
Other Amortization
0.280.280.280.28--
Stock-Based Compensation
0.260.260.230.331.031.54
Other Operating Activities
-0.44000.07-0.17-0.05
Change in Accounts Receivable
0.030.030.36-0.360.02-0.16
Change in Accounts Payable
0.040.04-1.12-0.260.950.74
Change in Other Net Operating Assets
0.050.050.03-0.070.030.17
Operating Cash Flow
-8.18-8.72-9.96-14.28-3.3-5.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Sale (Purchase) of Intangibles
-0.05-0.05----
Investing Cash Flow
--0.05----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Issuance of Common Stock
0.148.14-7.04-18.31
Other Financing Activities
-0.02-0.52--0.320.21-0.11
Financing Cash Flow
0.117.61-6.720.2118.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
0.15-0-0-0.070.170.03
Net Cash Flow
-7.92-1.16-9.96-7.63-2.9213.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Levered Free Cash Flow
-5.02-5.44-6.61-9.38-1.27-2.34
Unlevered Free Cash Flow
-5.02-5.44-6.61-9.38-1.27-2.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Income Tax Paid
--1.89-2.32-1.65-0.83-1.39
Change in Working Capital
0.130.13-0.73-0.681.010.76